Publication identifier(s): 8702946
A surface coat protein involved in immune evasion in Leishmaniids. Extremely fast evolving, almost completely disordered mucin-like protein. . Localization: Cell surface (experimental)
by homology
Contact email: handman@wehi.edu.au
Publication title: A Leucine-Rich Repeat Motif of Leishmania Parasite Surface Antigen 2 Binds to Macrophages through the Complement Receptor 3
Publication 1st author(s): Kedzierski
Publication Identifier(s): 15067069
Host organism: -1
Interaction detection method(s): fluorescence activated cell sorting
Interaction type: physical association
Identification method participant A: identification by antibody
Identification method participant B: identification by antibody
ID(s) interactor A: P11215
ID(s) interactor B: E9AGG4
Taxid interactor A: Homo sapiens
Taxid interactor B: Leishmania infantum
Biological role(s) interactor A: unspecified role
Biological role(s) interactor B: unspecified role
Experimental role(s) interactor A: unspecified role
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 135 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 16 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | yes | yes: 51, no: 9 |
NetGPI | no | yes: 0, no: 60 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005929 | cilium | 4 | 61 |
GO:0042995 | cell projection | 2 | 61 |
GO:0043226 | organelle | 2 | 61 |
GO:0043227 | membrane-bounded organelle | 3 | 61 |
GO:0110165 | cellular anatomical entity | 1 | 61 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 61 |
GO:0016020 | membrane | 2 | 18 |
GO:0005886 | plasma membrane | 3 | 3 |
Related structures:
AlphaFold database: E9AP07
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 3 |
GO:0004672 | protein kinase activity | 3 | 3 |
GO:0004674 | protein serine/threonine kinase activity | 4 | 3 |
GO:0016301 | kinase activity | 4 | 3 |
GO:0016740 | transferase activity | 2 | 3 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 3 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 3 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 6 | 8 | PF00675 | 0.777 |
CLV_PCSK_KEX2_1 | 6 | 8 | PF00082 | 0.777 |
CLV_PCSK_SKI1_1 | 158 | 162 | PF00082 | 0.497 |
CLV_PCSK_SKI1_1 | 7 | 11 | PF00082 | 0.784 |
DEG_SPOP_SBC_1 | 284 | 288 | PF00917 | 0.490 |
DEG_SPOP_SBC_1 | 292 | 296 | PF00917 | 0.475 |
DOC_AGCK_PIF_2 | 69 | 74 | PF00069 | 0.301 |
DOC_CYCLIN_yCln2_LP_2 | 10 | 16 | PF00134 | 0.486 |
DOC_MAPK_gen_1 | 252 | 260 | PF00069 | 0.337 |
DOC_MAPK_HePTP_8 | 102 | 114 | PF00069 | 0.278 |
DOC_MAPK_MEF2A_6 | 105 | 114 | PF00069 | 0.275 |
DOC_MAPK_MEF2A_6 | 252 | 260 | PF00069 | 0.371 |
DOC_PP2B_LxvP_1 | 10 | 13 | PF13499 | 0.498 |
DOC_USP7_MATH_1 | 291 | 295 | PF00917 | 0.480 |
DOC_USP7_MATH_1 | 33 | 37 | PF00917 | 0.394 |
DOC_USP7_MATH_1 | 343 | 347 | PF00917 | 0.302 |
DOC_WW_Pin1_4 | 287 | 292 | PF00397 | 0.514 |
DOC_WW_Pin1_4 | 293 | 298 | PF00397 | 0.631 |
LIG_14-3-3_CanoR_1 | 190 | 198 | PF00244 | 0.350 |
LIG_14-3-3_CanoR_1 | 233 | 238 | PF00244 | 0.303 |
LIG_Actin_WH2_2 | 177 | 192 | PF00022 | 0.289 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.654 |
LIG_BRCT_BRCA1_1 | 70 | 74 | PF00533 | 0.324 |
LIG_Clathr_ClatBox_1 | 162 | 166 | PF01394 | 0.280 |
LIG_FHA_1 | 145 | 151 | PF00498 | 0.460 |
LIG_FHA_1 | 44 | 50 | PF00498 | 0.367 |
LIG_FHA_1 | 90 | 96 | PF00498 | 0.347 |
LIG_FHA_2 | 204 | 210 | PF00498 | 0.383 |
LIG_FHA_2 | 257 | 263 | PF00498 | 0.331 |
LIG_FHA_2 | 275 | 281 | PF00498 | 0.440 |
LIG_FHA_2 | 63 | 69 | PF00498 | 0.449 |
LIG_FHA_2 | 92 | 98 | PF00498 | 0.416 |
LIG_LIR_Gen_1 | 128 | 136 | PF02991 | 0.339 |
LIG_LIR_Gen_1 | 225 | 234 | PF02991 | 0.367 |
LIG_LIR_Gen_1 | 71 | 78 | PF02991 | 0.501 |
LIG_LIR_Nem_3 | 103 | 107 | PF02991 | 0.364 |
LIG_LIR_Nem_3 | 128 | 132 | PF02991 | 0.366 |
LIG_LIR_Nem_3 | 168 | 174 | PF02991 | 0.352 |
LIG_LIR_Nem_3 | 214 | 218 | PF02991 | 0.463 |
LIG_LIR_Nem_3 | 71 | 75 | PF02991 | 0.364 |
LIG_PDZ_Class_2 | 362 | 367 | PF00595 | 0.307 |
LIG_PTAP_UEV_1 | 281 | 286 | PF05743 | 0.459 |
LIG_SH2_CRK | 215 | 219 | PF00017 | 0.299 |
LIG_SH2_STAT5 | 215 | 218 | PF00017 | 0.502 |
LIG_SH2_STAT5 | 91 | 94 | PF00017 | 0.518 |
LIG_SH3_3 | 248 | 254 | PF00018 | 0.488 |
LIG_SH3_3 | 279 | 285 | PF00018 | 0.491 |
LIG_SH3_3 | 93 | 99 | PF00018 | 0.460 |
LIG_SUMO_SIM_anti_2 | 106 | 111 | PF11976 | 0.271 |
LIG_SUMO_SIM_anti_2 | 46 | 51 | PF11976 | 0.330 |
LIG_SUMO_SIM_par_1 | 233 | 238 | PF11976 | 0.291 |
LIG_SUMO_SIM_par_1 | 256 | 263 | PF11976 | 0.344 |
LIG_TYR_ITIM | 102 | 107 | PF00017 | 0.372 |
LIG_TYR_ITIM | 213 | 218 | PF00017 | 0.291 |
LIG_UBA3_1 | 135 | 142 | PF00899 | 0.282 |
LIG_UBA3_1 | 162 | 169 | PF00899 | 0.274 |
MOD_CK1_1 | 128 | 134 | PF00069 | 0.379 |
MOD_CK1_1 | 179 | 185 | PF00069 | 0.417 |
MOD_CK1_1 | 203 | 209 | PF00069 | 0.367 |
MOD_CK1_1 | 295 | 301 | PF00069 | 0.606 |
MOD_CK1_1 | 36 | 42 | PF00069 | 0.430 |
MOD_CK2_1 | 203 | 209 | PF00069 | 0.384 |
MOD_CK2_1 | 274 | 280 | PF00069 | 0.433 |
MOD_CK2_1 | 298 | 304 | PF00069 | 0.443 |
MOD_CK2_1 | 91 | 97 | PF00069 | 0.466 |
MOD_Cter_Amidation | 60 | 63 | PF01082 | 0.506 |
MOD_GlcNHglycan | 114 | 117 | PF01048 | 0.616 |
MOD_GlcNHglycan | 121 | 124 | PF01048 | 0.604 |
MOD_GlcNHglycan | 194 | 197 | PF01048 | 0.630 |
MOD_GlcNHglycan | 202 | 205 | PF01048 | 0.607 |
MOD_GlcNHglycan | 206 | 209 | PF01048 | 0.595 |
MOD_GlcNHglycan | 218 | 221 | PF01048 | 0.603 |
MOD_GlcNHglycan | 225 | 229 | PF01048 | 0.661 |
MOD_GlcNHglycan | 237 | 240 | PF01048 | 0.592 |
MOD_GlcNHglycan | 242 | 245 | PF01048 | 0.554 |
MOD_GlcNHglycan | 25 | 28 | PF01048 | 0.705 |
MOD_GlcNHglycan | 300 | 303 | PF01048 | 0.702 |
MOD_GlcNHglycan | 314 | 317 | PF01048 | 0.699 |
MOD_GlcNHglycan | 346 | 349 | PF01048 | 0.501 |
MOD_GlcNHglycan | 99 | 102 | PF01048 | 0.658 |
MOD_GSK3_1 | 121 | 128 | PF00069 | 0.372 |
MOD_GSK3_1 | 130 | 137 | PF00069 | 0.389 |
MOD_GSK3_1 | 140 | 147 | PF00069 | 0.369 |
MOD_GSK3_1 | 176 | 183 | PF00069 | 0.503 |
MOD_GSK3_1 | 200 | 207 | PF00069 | 0.384 |
MOD_GSK3_1 | 264 | 271 | PF00069 | 0.355 |
MOD_GSK3_1 | 276 | 283 | PF00069 | 0.484 |
MOD_GSK3_1 | 287 | 294 | PF00069 | 0.664 |
MOD_GSK3_1 | 32 | 39 | PF00069 | 0.607 |
MOD_GSK3_1 | 326 | 333 | PF00069 | 0.405 |
MOD_GSK3_1 | 64 | 71 | PF00069 | 0.454 |
MOD_GSK3_1 | 73 | 80 | PF00069 | 0.389 |
MOD_N-GLC_1 | 112 | 117 | PF02516 | 0.553 |
MOD_N-GLC_2 | 273 | 275 | PF02516 | 0.767 |
MOD_NEK2_1 | 112 | 117 | PF00069 | 0.381 |
MOD_NEK2_1 | 121 | 126 | PF00069 | 0.390 |
MOD_NEK2_1 | 165 | 170 | PF00069 | 0.385 |
MOD_NEK2_1 | 189 | 194 | PF00069 | 0.410 |
MOD_NEK2_1 | 21 | 26 | PF00069 | 0.573 |
MOD_NEK2_1 | 274 | 279 | PF00069 | 0.479 |
MOD_OFUCOSY | 70 | 77 | PF10250 | 0.568 |
MOD_PKA_1 | 62 | 68 | PF00069 | 0.330 |
MOD_PKA_2 | 189 | 195 | PF00069 | 0.377 |
MOD_Plk_1 | 112 | 118 | PF00069 | 0.448 |
MOD_Plk_1 | 224 | 230 | PF00069 | 0.396 |
MOD_Plk_1 | 330 | 336 | PF00069 | 0.362 |
MOD_Plk_2-3 | 324 | 330 | PF00069 | 0.334 |
MOD_Plk_2-3 | 68 | 74 | PF00069 | 0.395 |
MOD_Plk_4 | 131 | 137 | PF00069 | 0.399 |
MOD_Plk_4 | 158 | 164 | PF00069 | 0.425 |
MOD_Plk_4 | 246 | 252 | PF00069 | 0.405 |
MOD_Plk_4 | 45 | 51 | PF00069 | 0.402 |
MOD_Plk_4 | 80 | 86 | PF00069 | 0.400 |
MOD_ProDKin_1 | 287 | 293 | PF00069 | 0.511 |
MOD_ProDKin_1 | 295 | 301 | PF00069 | 0.585 |
MOD_SUMO_rev_2 | 261 | 267 | PF00179 | 0.344 |
MOD_SUMO_rev_2 | 324 | 333 | PF00179 | 0.342 |
MOD_SUMO_rev_2 | 97 | 107 | PF00179 | 0.309 |
TRG_ENDOCYTIC_2 | 104 | 107 | PF00928 | 0.391 |
TRG_ENDOCYTIC_2 | 215 | 218 | PF00928 | 0.304 |
TRG_ER_diArg_1 | 5 | 7 | PF00400 | 0.700 |
TRG_Pf-PMV_PEXEL_1 | 55 | 59 | PF00026 | 0.536 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P2L4 | Leptomonas seymouri | 45% | 100% |
A0A0N1HZ17 | Leptomonas seymouri | 30% | 100% |
A0A0N1I7S5 | Leptomonas seymouri | 30% | 72% |
A0A0S4ILC9 | Bodo saltans | 34% | 66% |
A0A0S4IVN7 | Bodo saltans | 35% | 96% |
A0A3Q8I9A6 | Leishmania donovani | 65% | 95% |
A0A3Q8I9D0 | Leishmania donovani | 56% | 100% |
A0A3Q8IIJ9 | Leishmania donovani | 33% | 100% |
A0A3Q8IK15 | Leishmania donovani | 43% | 70% |
A0A3S5H6D6 | Leishmania donovani | 33% | 100% |
A0A3S7WP69 | Leishmania donovani | 21% | 100% |
A0A3S7WPB2 | Leishmania donovani | 24% | 100% |
A0A3S7X4J4 | Leishmania donovani | 33% | 100% |
A4H4D2 | Leishmania braziliensis | 22% | 100% |
A4H4G6 | Leishmania braziliensis | 24% | 100% |
A4H5P0 | Leishmania braziliensis | 29% | 100% |
A4HBX3 | Leishmania braziliensis | 37% | 81% |
A4HJC8 | Leishmania braziliensis | 30% | 100% |
A4HSL2 | Leishmania infantum | 21% | 100% |
A4HTX9 | Leishmania infantum | 34% | 100% |
A4HVB0 | Leishmania infantum | 52% | 91% |
A4I6S2 | Leishmania infantum | 43% | 83% |
A4I6S4 | Leishmania infantum | 33% | 100% |
D1GJ51 | Leishmania infantum | 54% | 79% |
E8NHG5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 44% | 83% |
E8NHP8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 33% | 100% |
E9ACQ0 | Leishmania major | 25% | 100% |
E9AG65 | Leishmania infantum | 24% | 100% |
E9AGG5 | Leishmania infantum | 59% | 88% |
E9AGG9 | Leishmania infantum | 56% | 68% |
E9AGH0 | Leishmania infantum | 65% | 97% |
E9AKJ6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 21% | 100% |
E9AKM8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 25% | 100% |
E9AMQ9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 31% | 100% |
E9AP02 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |
E9AP03 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
E9AP05 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 57% | 71% |
E9AP08 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 82% | 87% |
E9AVA1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 38% | 80% |
E9B1U3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 43% | 81% |
E9B1U4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 37% | 100% |
E9B1U5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 43% | 87% |
E9B1U6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 34% | 100% |
P21978 | Leishmania amazonensis | 61% | 77% |
Q25331 | Leishmania major | 57% | 94% |
Q4Q6B6 | Leishmania major | 32% | 100% |
Q4Q6B7 | Leishmania major | 31% | 100% |
Q4Q6B8 | Leishmania major | 41% | 69% |
Q4QGI0 | Leishmania major | 57% | 72% |
Q4QGI4 | Leishmania major | 47% | 68% |
Q4QGI6 | Leishmania major | 61% | 67% |
Q4QGJ4 | Leishmania major | 56% | 94% |
Q4QGJ7 | Leishmania major | 58% | 94% |
Q4QGK6 | Leishmania major | 57% | 94% |
Q4QGK8 | Leishmania major | 49% | 72% |
Q4QGL2 | Leishmania major | 49% | 72% |
Q4QGL4 | Leishmania major | 56% | 95% |
Q4QGL5 | Leishmania major | 47% | 67% |
Q4QHW6 | Leishmania major | 31% | 100% |
Q4QJB2 | Leishmania major | 22% | 100% |